Brief: Chemometec Q1 EBITDA At Dkk 43,4 mln

ChemoMetec A/S

04/11/2021 07:51

Nov 4 (Reuters) - Chemometec A/S  CHEMM.CO :
    * CHEMOMETEC A/S - Q1 EBITDA AT DKK 43,4 MILLION VERSUS DKK 30,8 MILLION YEAR AGO
    * CHEMOMETEC A/S - Q1 REVENUE DKK 85.0 MILLION
    * CHEMOMETEC A/S - DUE TO THE GLOBAL SUPPLY SITUATION AND THE CONSEQUENT LACK OF COMPONENTS,
IT IS
NOW EXPECTED THAT THE COMPLETE DEVELOPMENT OF THE NEW CELL COUNTER XCYTOMATIC WILL BE POSTPONED
FOR A FEW MONTHS FROM THE END OF 2021 TO APRIL 2022.
    * CHEMOMETEC A/S - THE GLOBAL SUPPLY SITUATION FOR RAW MATERIALS HAS NOT YET AFFECTED
CHEMOMETEC'S
DELIVERY CAPABILITY FOR FINISHED PRODUCTS, BUT THERE IS INCREASED UNCERTAINTY ABOUT FUTURE
DELIVERY SECURITY IF THE GLOBAL COMPONENT SHORTAGE CONTINUES INTO 2022.
    * CHEMOMETEC A/S - THE EXPECTATIONS FOR THE FINANCIAL YEAR 2021/22, WHICH WAS LAST UPDATED
ON 27
OCTOBER 2021, ARE MAINTAINED.

Source text for Eikon:  ID:nGNE20DNCv 
Further company coverage:  CHEMM.CO 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))